Diaryl Urea: A Privileged Structure in Anticancer Agents

E-ISSN： 1875-533x|23|15|1528-1548

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.15, 2016-05, pp. : 1528-1548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 13, 2011-11 ,pp. : 1130-1142

Bentham Science Publishers

Access to resources Recommend Favorite

Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 10, 2017-06 ,pp. : 869-901

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design of Novel Anticancer Agents

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Structure Activity Correlation Model on Aroylindole Derivatives as Anticancer Agents

Letters in Drug Design & Discovery, Vol. 15, Iss. 2, 2018-01 ,pp. : 143-153

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 10, 2011-09 ,pp. : 881-887

Bentham Science Publishers

Access to resources Recommend Favorite